Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
3Customers
2Debt Items
0Related Chains
Source-Backed Evidence Depth
MediciNova, Inc. (MNOV) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
8Total relationships
3Distinct source URLs
6High confidence
0.835Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
MediciNova, Inc. Suppliers
Ticker
Name
Confidence
Evidence
LUCID-CAPITAL-MARKETS-LLC
LUCID-CAPITAL-MARKETS-LLC
92%
the Company entered into an equity distribution agreement with Lucid Capital Markets, LLC (the "Agent") to sell shares of the Company's common stock
TAISHO-PHARMACEUTICAL-CO-LTD
TAISHO-PHARMACEUTICAL-CO-LTD
92%
For the MN-166 (ibudilast) development program, we have historically sourced and imported delayed-release ibudilast capsules, marketed in Japan as Pinatos®, from Taisho.
MediciNova, Inc. Customers
Ticker
Name
Confidence
Evidence
MAYO-FOUNDATION-FOR-MEDICAL-EDUCATION-AND-RESEAR
MAYO-FOUNDATION-FOR-MEDICAL-EDUCATION-AND-RESEAR
90%
In December 2024, the Company entered into an agreement with Mayo Foundation for Medical Education and Research (Mayo), to support clinical research services to evaluate the efficacy of MN-166 (ibudi…
EUROPE-LIMITED-MEDICINOVA-EUROPE-GMBH-MEDICINOVA
EUROPE-LIMITED-MEDICINOVA-EUROPE-GMBH-MEDICINOVA
62%
use our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including t…
MEDICINOVA-JAPAN-INC
MEDICINOVA-JAPAN-INC
62%
use our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including t…
MediciNova, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
MNOV-DEBT
Debt stack $165,198
90%
Market cache reports total debt of $165,198.
MNOV-DEBT-11034
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2012-12-31.
MediciNova, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for MediciNova, Inc..
MediciNova, Inc. Ownership
Holder
Name
Confidence
Evidence
MNOV-OWNER-BARCLAYS-PLC
BARCLAYS PLC
90%
13F overlay lists BARCLAYS PLC as top holder; 30 tracked holders.
MediciNova, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
